Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03231644

Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry

Status
Recruiting
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
Tovah Burstein · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The FD/MAS Patient Registry is an IRB-approved research study that that invites the patients and families to help answer some of the biggest questions about FD/MAS by completing questionnaires about their lives with FD or MAS. Have you enrolled in the FD/MAS Patient Registry yet? Are you up-to-date on your surveys? Take a trip to www.fdmasregistry.org today to learn more about the project, enroll, complete your surveys, or make sure you aren't due to provide more info! The FD/MAS Patient Registry: Your story powers research.

Detailed description

The FD/MAS Patient Registry is an IRB approved research project that allows patients and families to share their experiences with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by completing a series of surveys. The surveys were created in collaboration with patients, parents, clinicians and researchers, so that the data can be used to answer some of the most important questions about FD/MAS, including: the way the disease develops over time (its "natural history"), the patient experience of the disease, and its impact on quality of life, how and when diagnoses are made, the scope of treatments in use, what surgical techniques work best, and for whom, what other medical interventions work best, and for whom, what social services and therapies are useful, the costs of care to patients and their families, issues that concern patients (such as the impact of pregnancy on FD, or children feeling different and facing stigma), and which research questions and support programs you think are important to fund. Participation is free and convenient for people with FD/MAS and their legal guardians. You can join today at www.fdmasregistry.org.

Conditions

Timeline

Start date
2016-10-31
Primary completion
2028-10-01
Completion
2028-10-01
First posted
2017-07-27
Last updated
2025-08-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03231644. Inclusion in this directory is not an endorsement.